Gabapentin, pregabalin and vigabatrin quantification in human serum by GC-MS after hexyl chloroformate derivatization

15Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A simple, sensitive and robust method for simultaneous determination of antiepileptic drugs (gabapentin, pregabalin and vigabatrin) in human serum using GC-MS was developed and validated for clinical toxicology purposes. This method employs an emerging class of derivatization agents - alkyl chloroformates allowing the efficient and rapid derivatization of both the amino and carboxylic groups of the tested antiepileptic drugs within seconds. The derivatization protocol was optimized using the Design of Experiment statistical methodology, and the entire sample preparation requires less than 5 min. Linear calibration curves were obtained in the concentration range from 0.5 to 50.0 mg/L, with adequate accuracy (97.9-109.3%) and precision (< 12.1%). The method was successfully applied to quantification of selected γ-aminobutyric acid analogs in the serum of patients in both therapeutic and toxic concentration ranges.

Cite

CITATION STYLE

APA

Hložek, T., Bursová, M., Coufal, P., & Čabala, R. (2016). Gabapentin, pregabalin and vigabatrin quantification in human serum by GC-MS after hexyl chloroformate derivatization. Journal of Analytical Toxicology, 40(9), 749–753. https://doi.org/10.1093/jat/bkw070

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free